Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net (loss) income	$ (22,613)	$ (15,192)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	41,949	45,608
Gain on sale of investment		(250)
Amortization of deferred financing costs	1,337	1,343
Change in fair value of contingent consideration	(97)	1,953
Loss on disposal of equipment and improvements	1,052
Share-based compensation expense	9,475	4,822
Impairment of intangible assets	782	6,632
Accrued interest expense	(4,133)	230
Deferred taxes, net	(3,411)	(8,967)
Other	(325)	(266)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	1,581	391
Other receivables	7,236	(1,489)
Inventory	569	175
Other current assets	(512)	(788)
Operating lease right-of-use assets	3,889	3,161
Other assets	(482)	(446)
Related parties, net	(1,931)	1,707
Accounts payable	(5,828)	(1,135)
Accrued expenses	(13,370)	(11,387)
Settlement processing funds, net	26,198	(84,946)
Operating lease liabilities	(3,849)	(3,244)
Other	(52)
Net cash provided by (used in) operating activities	37,465	(62,088)
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired		(3,030)
Purchase of equipment and improvements	(8,674)	(13,303)
Acquisition of intangible assets	(2,921)	(4,452)
Net proceeds from sale of investments		250
Collection of deferred cash consideration		4,406
Collections of notes receivable	24	1,419
Net cash used in investing activities	(11,571)	(14,710)
Cash flows from financing activities:
Proceeds from long-term debt	185,928	212,647
Repayments of long-term debt	(262,107)	(238,382)
Deferred financing costs paid		(2)
Contingent consideration paid	(1,006)	(5,578)
Deferred cash consideration paid	(545)
Secondary offering proceeds		18,984
Repurchases of shares to satisfy minimum tax withholding	(1,195)	(1,638)
Proceeds from issuance of redeemable preferred stock	149,250
Redeemable preferred stock issuance costs	(1,660)
Proceeds from exercise of common stock options	566	291
Distribution to non-controlling interests holders	(74)	(6,440)
Net cash provided by (used in) financing activities	69,157	(20,118)
Effect of exchange rate changes on cash and cash equivalents	(8,395)	(1,409)
Net increase (decrease) in cash and cash equivalents	86,656	(98,325)
Cash and cash equivalents, beginning of period	304,089	350,697
Cash and cash equivalents, end of period	$ 390,745	$ 252,372